Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Advate in Previously Untreated Chinese Patients With Moderate to Severe Hemophilia A
CTR20160372Phase 4Active
- Sponsor
- Baxter International Inc.
- Start
- Sep 2016
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of recombinant human coagulation factor VIII in hemophilia A, sponsored by Baxter International Inc.. Started Sep 2016; status: active.
02
Drugs
recombinant human coagulation factor VIII
03
Conditions
hemophilia A
Beyond the preview
Go deeper on CTR20160372.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20160372.